HSA
AVNS

Hussman Strategic Advisors’s Avanos Medical AVNS Stock Holding History

Hussman Strategic Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-15,625
Closed -$710K – 192
2014
Q4 		$710K Buy
+15,625
New +$614K 0.07% 136

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
RP
RR Partners New York $929M AUM 110.28% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Hussman Strategic Advisors's AVNS Position: Q1 2015 in Review

Hussman Strategic Advisors sold out of Avanos Medical (AVNS) in Q1 2015, closing a stake of 15,625 shares — an estimated $710K sold.

Hussman Strategic Advisors first reported a position in AVNS in Q4 2014 and held it in 1 quarter. The position peaked at $710K in Q4 2014. 448 funds tracked by Wall St. Rank hold AVNS as of Q1 2015.

  • Hussman Strategic Advisors reported no remaining Avanos Medical position as of Q1 2015 after selling out during the quarter.
  • Hussman Strategic Advisors sold 15,625 Avanos Medical shares in Q1 2015, an estimated $710K.
  • Hussman Strategic Advisors first reported a position in Avanos Medical in Q4 2014 and held it in 1 quarter.
  • Hussman Strategic Advisors's Avanos Medical position peaked at $710K in Q4 2014.
  • 448 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2015.

Based on Hussman Strategic Advisors's 13F filing for Q1 2015, filed 1 May 2015.